Uses and limitations of IgG4 positive plasma cells in evaluating ulcerative colitis

Authors

  • Kian Keyashian Department of Internal Medicine, Division of Gastroenterology, Oregon Health & Science University, Portland, Oregon, USA
  • Eleonora Duregon Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA
  • Brian T. Brinkerhoff Department of Pathology, OHSU, Portland, Oregon; Chinook Regional Hospital, Alberta Health Services, Alberta, USA
  • Laura Bradley Department of Internal Medicine, Division of Gastroenterology, Oregon Health & Science University, Portland, Oregon; Department of Internal Medicine, University of California, Davis, California, USA
  • Benjamin Larson Department of Internal Medicine, Division of Gastroenterology, Oregon Health & Science University, Portland, Oregon; Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Jeong Lim Biostatistics and Design Program, School of Public Health, OHSU, Portland, Oregon, USA
  • Nir Modiano Department of Internal Medicine, Division of Gastroenterology, Oregon Health & Science University, Portland, Oregon, USA
  • Judy Collins Department of Internal Medicine, Division of Gastroenterology, Oregon Health & Science University, Portland, Oregon, USA
  • Terry K. Morgan Department of Pathology, OHSU, Portland, Oregon, USA
  • Jody E. Hooper Department of Pathology, The Johns Hopkins University, Baltimore, Maryland, USA

DOI:

https://doi.org/10.15403/jgld.2014.1121.264.igg

Keywords:

.

Abstract

.

Downloads

Published

2017-12-01

How to Cite

1.
Keyashian K, Duregon E, Brinkerhoff BT, Bradley L, Larson B, Lim J, Modiano N, Collins J, Morgan TK, Hooper JE. Uses and limitations of IgG4 positive plasma cells in evaluating ulcerative colitis. JGLD [Internet]. 2017 Dec. 1 [cited 2026 Jul. 19];26(4):425-9. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/1018

Issue

Section

Letters